Related Experiment Videos
Posterior subcapsular cataracts associated with megestrol acetate therapy
1Infectious Disease Service, William Beaumont Army Medical Center, El Paso, Texas.
Journal of Cataract and Refractive Surgery
|January 1, 1993
Summary
Megestrol acetate, used to stimulate appetite in an HIV-infected man, was linked to posterior subcapsular cataracts. The drug's glucocorticoid effects may have contributed to this vision complication.
Area of Science:
- Ophthalmology
- Endocrinology
- Virology
Background:
- Megestrol acetate is prescribed to manage appetite loss in patients with human immunodeficiency virus (HIV).
- Glucocorticoids are known to have various systemic and ocular side effects.
Observation:
- A case study involving an HIV-infected male patient treated with megestrol acetate for eight weeks.
- The patient presented with bilateral posterior subcapsular cataracts during the treatment period.
Findings:
- A direct association was observed between megestrol acetate use and the development of posterior subcapsular cataracts.
- The glucocorticoid properties of megestrol acetate are hypothesized as a contributing factor to the cataract formation.
Implications:
- This case highlights a potential ocular side effect of megestrol acetate, particularly in immunocompromised patients.
- Further research is warranted to elucidate the mechanism and prevalence of megestrol acetate-induced cataracts in HIV patients.